Clinical Trial Search

Primary: Number and Prevalence of Metastases of Blue Nodes in the ALND Specimen (Nodes Draining the Breast). — 0 participants

Primary: Concordance of Blue Dye and Lymphoseek — 1.0000 Proportion of Lymph Nodes

Primary: Postoperative Draining Time — 31; 32 days

Primary: the Number of Lymph Nodes: 1. Identified Within Each Lymph Node Group, 2.Located Within the Submandibular Gland, and 3. Within the Fibrofatty Contents Lying Deep to the…

Primary: 68Ga-DOTANOC Uptake in Lymphomas With PET/CT — 3.1 Standardized Uptake Value

Primary: Number of Participants With Pathologically Proven Lymph Node Metastasis — 1 participants

Primary: Dose Limiting Toxicity (DLT) Rate by the NCI Common Toxicity Criteria (CTCAE) v2.0 and the Method of Przepiorka et al (Protocol Appendix I) — 0; 0; 0; 0 proportion of…

Primary: Injection Site Clearance for Lymphoseek and 99mTc-Sulfur Colloid (SC). — 1.78; 0.045 minutes

Primary: Concordance of Blue Dye and Lymphoseek — 0.9767 Proportion of Lymph Nodes

Primary: Overall Survival Rate

Primary: Primary Efficacy Parameters of Sensitivity of High Resolution Magnetic Resonance Imaging With Lymphotrophic Superparamagnetic Nanoparticles (LSN MRI) — 85.5 percentage…

Primary: Efficacy of Lymphoseek for Detection of Sentinel Nodes — 16 Participants

Primary: Percentage of Participants With Transient Hypoparathyroidism, as Defined by a Day 1 Serum Parathyroid Hormone (PTH) Level of < 10 pg/ml — 24.1; 33.3 percentage of…

Primary: Equivalence of ICG and Real Time Lymphangiography to technetium99 and Blue Dye in Localizing Sentinel Nodes — 1.87 number of sentinel nodes per patient

Primary: Percentage Change (From Baseline to 24 Hours) Between Metastatic and Benign Nodes — -33.6; -46.9 Percentage Change

Primary: Sentinel Lymph Node Positivity — 2 Participants

Primary: 5-year Disease-Free Survival — 84.4; 87.8 percentage of participants — p=0.004

Primary: Subjects in Which the SLN(s) Are Identified — 27 Participants

Primary: Negative Predictive Value of Sentinel Lymph Node Prediction of Metastatic Disease — 98.8 percentage of patients

Primary: Treatment Success and Feasibility of Autologous Activated T-cells Infusion, Determined by Number of Participants That Achieved Target-Activated T-cell Dose Without DLT…

Primary: Average Number of Lymph Nodes Identified Intraoperatively Per Subject — 3.30 nodes per subject

Primary: Sensitivity and Specificity of FDG Positron Emission Mammography (PEM) in Identifying Axillary Lymph Node (ALN) Metastases From Breast Cancer — 83.3; 52.0 percentage of…

Primary: Tumor Response Rate (RR) (Percentage of Participants Exhibiting Complete Response [CR] or Complete Response Unconfirmed [CRu] or Partial Response [PR]) — 0; 0; 0; 0…

Primary: Percentage of Leukocyte Subsets Including B Lymphocytes, Classical B Lymphocytes, Double Negative B Lymphocytes, Naive B Lymphocytes, Plasmablast and Transitional B…

Primary: Assessing a Change in Bioimpedance Spectroscopy (BIS) — 1.3; 1.8 Change of score on a scale

Primary: Number of Participants With Clinical Success at 1 to 6 Months Post-Therapy as Assessed by Imaging — 57 Participants

Primary: Post-operative Wound Drainage. — 892.5; 762.5; 565; 590 ml — p=0.704

Primary: Lymph Movement Measured by ICG Lymphography. — 5; 5; 0; 0 Participants

Primary: Proportion of Lymph Nodes Identified by IC2000/SPY-PHI Compared to the Proportion of Lymph Nodes Identified by Tc99m/Gamma Probe — 360; 266 Lymph Nodes — p=<0.0001

Primary: COVID-19 Vaccination on Contralateral vs Ipsilateral Arm — 432; 435; 331; 122 Participants